Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025 ...

This unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

Cohort B of the Phase 2 study indicates all doses of enpatoran were associated with higher BICLA response rates compared with placebo, though the ...

A noteworthy case study. Why did a 19-year-old otherwise healthy woman suddenly develop an itchy rash on her face, ears, and ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...

Below, Kiana Cornejo, 24, shares her story about being pregnant with lupus and the challenges she has faced both during and ...

Most lupus patients are women and many are Black women. They can suffer rashes, fatigue and kidney problems but may not know ...

UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...

AstraZeneca Plc said a handful of patients with lupus went into remission after getting an experimental treatment, as the UK ...